AKRO, NasdaqGS
Akero Therapeutics, Inc. (AKRO)
Price (as of October 24)
42.49USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
InVivo Therapeutics Holdings Corp. |
-0.63 |
|
Altimmune, Inc. |
-0.6 |
|
Rigel Pharmaceuticals, Inc. |
-0.39 |
|
Oragenics, Inc. |
-0.39 |
|
Entasis Therapeutics Holdings Inc. |
-0.36 |
|
IMV Inc. |
-0.09 |
|
Vigil Neuroscience, Inc. |
-0.1 |
|
Armata Pharmaceuticals, Inc. |
-0.04 |
|
Aerovate Therapeutics, Inc. |
-0.09 |
|
Voyager Therapeutics, Inc. |
-0.01 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Aileron Therapeutics, Inc. |
0.49 |
|
BioNTech SE |
0.39 |
|
Akouos, Inc. |
0.36 |
|
Halozyme Therapeutics, Inc. |
0.27 |
|
Mersana Therapeutics, Inc. |
0.26 |
|
Moderna, Inc. |
0.08 |
|
Aligos Therapeutics, Inc. |
0.11 |
|
Synthetic Biologics, Inc. |
0.05 |
|
Aditxt, Inc. |
0.17 |
|
Rani Therapeutics Holdings, Inc. |
0.02 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
InVivo Therapeutics Holdings Corp. |
-0.4 |
|
Altimmune, Inc. |
-0.25 |
|
Graybug Vision, Inc. |
-0.19 |
|
IMV Inc. |
-0.18 |
|
Intercept Pharmaceuticals, Inc. |
-0.17 |
|
Eton Pharmaceuticals, Inc. |
-0.06 |
|
Aerovate Therapeutics, Inc. |
-0.09 |
|
ORIC Pharmaceuticals, Inc. |
-0.05 |
|
Relmada Therapeutics, Inc. |
-0.01 |
|
First Wave BioPharma, Inc. |
-0.01 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Agios Pharmaceuticals, Inc. |
0.37 |
|
Adaptive Biotechnologies Corporation |
0.34 |
|
Aadi Bioscience, Inc. |
0.34 |
|
Adaptimmune Therapeutics plc |
0.34 |
|
Adicet Bio, Inc. |
0.33 |
|
AbCellera Biologics Inc. |
0.23 |
|
Alector, Inc. |
0.27 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Aileron Therapeutics, Inc. |
0.1 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Cybin Inc. |
-0.16 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
|
Miromatrix Medical Inc. |
-0.13 |
|
Cingulate Inc. |
-0.13 |
|
Verastem, Inc. |
-0.13 |
|
Alpha Tau Medical Ltd. |
-0.13 |
|
Enlivex Therapeutics Ltd. |
-0.12 |
|
Athira Pharma, Inc. |
-0.11 |
|
Exelixis, Inc. |
-0.11 |
|
Arrowhead Pharmaceuticals, Inc. |
-0.11 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Albireo Pharma, Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
Agios Pharmaceuticals, Inc. |
0.3 |
|
Aldeyra Therapeutics, Inc. |
0.29 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Alector, Inc. |
0.27 |
|
Akouos, Inc. |
0.25 |
|
ADMA Biologics, Inc. |
0.25 |
|
AbCellera Biologics Inc. |
0.23 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Cybin Inc. |
-0.16 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
|
Miromatrix Medical Inc. |
-0.13 |
|
Cingulate Inc. |
-0.13 |
|
Verastem, Inc. |
-0.13 |
|
Alpha Tau Medical Ltd. |
-0.13 |
|
Enlivex Therapeutics Ltd. |
-0.12 |
|
Athira Pharma, Inc. |
-0.11 |
|
Exelixis, Inc. |
-0.11 |
|
Arrowhead Pharmaceuticals, Inc. |
-0.11 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Albireo Pharma, Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
Agios Pharmaceuticals, Inc. |
0.3 |
|
Aldeyra Therapeutics, Inc. |
0.29 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Alector, Inc. |
0.27 |
|
Akouos, Inc. |
0.25 |
|
ADMA Biologics, Inc. |
0.25 |
|
AbCellera Biologics Inc. |
0.23 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
InVivo Therapeutics Holdings Corp. |
-0.63 |
|
Altimmune, Inc. |
-0.6 |
|
Sunshine Biopharma, Inc. |
-0.53 |
|
Cosmos Holdings Inc. |
-0.43 |
|
West Pharmaceutical Services, Inc. |
-0.4 |
|
Rigel Pharmaceuticals, Inc. |
-0.03 |
|
Oragenics, Inc. |
-0.1 |
|
Nutex Health Inc. |
0.01 |
|
NuVasive, Inc. |
-0.09 |
|
Entasis Therapeutics Holdings Inc. |
0.03 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Aileron Therapeutics, Inc. |
0.49 |
|
Harvard Bioscience, Inc. |
0.43 |
|
BioNTech SE |
0.39 |
|
Sight Sciences, Inc. |
0.37 |
|
Akouos, Inc. |
0.36 |
|
SI-BONE, Inc. |
0.01 |
|
Pfizer Inc. |
0.03 |
|
UnitedHealth Group Incorporated |
0.02 |
|
Renalytix Plc |
0.06 |
|
Johnson & Johnson |
0.02 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
InVivo Therapeutics Holdings Corp. |
-0.4 |
|
Altimmune, Inc. |
-0.25 |
|
Cosmos Holdings Inc. |
-0.25 |
|
Graybug Vision, Inc. |
-0.19 |
|
Sunshine Biopharma, Inc. |
-0.19 |
|
Ekso Bionics Holdings, Inc. |
-0.05 |
|
NuVasive, Inc. |
-0.09 |
|
IMV Inc. |
-0.09 |
|
Intercept Pharmaceuticals, Inc. |
-0.07 |
|
Amgen Inc. |
-0.14 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Agios Pharmaceuticals, Inc. |
0.37 |
|
Adaptive Biotechnologies Corporation |
0.34 |
|
Aadi Bioscience, Inc. |
0.34 |
|
Adaptimmune Therapeutics plc |
0.34 |
|
Adicet Bio, Inc. |
0.33 |
|
AbCellera Biologics Inc. |
0.23 |
|
Alector, Inc. |
0.27 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Aileron Therapeutics, Inc. |
0.1 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Sunshine Biopharma, Inc. |
-0.19 |
|
The Ensign Group, Inc. |
-0.16 |
|
Cybin Inc. |
-0.16 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
|
Amedisys, Inc. |
-0.15 |
|
Amgen Inc. |
-0.14 |
|
Evolent Health, Inc. |
-0.14 |
|
Covetrus, Inc. |
-0.13 |
|
Amphastar Pharmaceuticals, Inc. |
-0.13 |
|
Miromatrix Medical Inc. |
-0.13 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Albireo Pharma, Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
Agios Pharmaceuticals, Inc. |
0.3 |
|
Aldeyra Therapeutics, Inc. |
0.29 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Acadia Healthcare Company, Inc. |
0.28 |
|
Alector, Inc. |
0.27 |
|
Accolade, Inc. |
0.26 |
|
Akouos, Inc. |
0.25 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Sunshine Biopharma, Inc. |
-0.19 |
|
The Ensign Group, Inc. |
-0.16 |
|
Cybin Inc. |
-0.16 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
|
Amedisys, Inc. |
-0.15 |
|
Amgen Inc. |
-0.14 |
|
Evolent Health, Inc. |
-0.14 |
|
Covetrus, Inc. |
-0.13 |
|
Amphastar Pharmaceuticals, Inc. |
-0.13 |
|
Miromatrix Medical Inc. |
-0.13 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Albireo Pharma, Inc. |
0.33 |
|
Adaptive Biotechnologies Corporation |
0.32 |
|
Agios Pharmaceuticals, Inc. |
0.3 |
|
Aldeyra Therapeutics, Inc. |
0.29 |
|
Affimed N.V. |
0.29 |
|
ADC Therapeutics SA |
0.28 |
|
Acadia Healthcare Company, Inc. |
0.28 |
|
Alector, Inc. |
0.27 |
|
Accolade, Inc. |
0.26 |
|
Akouos, Inc. |
0.25 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Venus Acquisition Corporation |
-0.79 |
|
Alpha Capital Acquisition Company |
-0.79 |
|
TOP Financial Group Limited |
-0.77 |
|
Venus Acquisition Corporation |
-0.75 |
|
Ventoux CCM Acquisition Corp. |
-0.66 |
|
Swiftmerge Acquisition Corp. |
-0.25 |
|
Duddell Street Acquisition Corp. |
-0.27 |
|
Alpha Capital Acquisition Company |
-0.49 |
|
DiamondHead Holdings Corp. |
-0.13 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Social Capital Suvretta Holdings Corp. I |
0.83 |
|
Brookline Capital Acquisition Corp. |
0.8 |
|
B. Riley Principal 150 Merger Corp. |
0.59 |
|
Bullpen Parlay Acquisition Company |
0.52 |
|
Focus Impact Acquisition Corp. |
0.5 |
|
Aileron Therapeutics, Inc. |
0.1 |
|
LMF Acquisition Opportunities, Inc. |
0.07 |
|
Springwater Special Situations Corp. |
0.11 |
|
Maxpro Capital Acquisition Corp. |
0.32 |
|
The Growth for Good Acquisition Corporation |
0.24 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
TOP Financial Group Limited |
-0.67 |
|
Venus Acquisition Corporation |
-0.63 |
|
Alpha Capital Acquisition Company |
-0.6 |
|
Venus Acquisition Corporation |
-0.57 |
|
Alpha Capital Acquisition Company |
-0.51 |
|
Ventoux CCM Acquisition Corp. |
-0.41 |
|
Duddell Street Acquisition Corp. |
-0.27 |
|
InVivo Therapeutics Holdings Corp. |
-0.15 |
|
L&F Acquisition Corp. |
-0.36 |
|
Nocturne Acquisition Corporation |
-0.35 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Social Capital Suvretta Holdings Corp. I |
0.65 |
|
Brookline Capital Acquisition Corp. |
0.63 |
|
Agios Pharmaceuticals, Inc. |
0.37 |
|
B. Riley Principal 150 Merger Corp. |
0.36 |
|
Adaptive Biotechnologies Corporation |
0.34 |
|
Aadi Bioscience, Inc. |
0.17 |
|
Adaptimmune Therapeutics plc |
0.2 |
|
Adicet Bio, Inc. |
0.07 |
|
Aehr Test Systems |
0.2 |
|
Maxpro Capital Acquisition Corp. |
0.32 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
TOP Financial Group Limited |
-0.67 |
|
Venus Acquisition Corporation |
-0.59 |
|
Alpha Capital Acquisition Company |
-0.57 |
|
Venus Acquisition Corporation |
-0.49 |
|
Alpha Capital Acquisition Company |
-0.49 |
|
Ventoux CCM Acquisition Corp. |
-0.41 |
|
Atlantic Coastal Acquisition Corp. II |
-0.36 |
|
L&F Acquisition Corp. |
-0.36 |
|
Nocturne Acquisition Corporation |
-0.35 |
|
Forafric Global PLC |
-0.32 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Social Capital Suvretta Holdings Corp. I |
0.64 |
|
Brookline Capital Acquisition Corp. |
0.57 |
|
FIRST TRUST ACTIVE FACTOR SMALL CAP ETF |
0.38 |
|
ALPS Clean Energy ETF |
0.37 |
|
Virtus AllianzGI Diversified Income & Convertible Fund |
0.37 |
|
Anfield U.S. Equity Sector Rotation ETF |
0.37 |
|
iShares MSCI ACWI ex US ETF |
0.36 |
|
Armada Hoffler Properties, Inc. |
0.36 |
|
AI Powered Equity ETF |
0.36 |
|
First Trust Active Factor Large Cap ETF |
0.36 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
TOP Financial Group Limited |
-0.67 |
|
Venus Acquisition Corporation |
-0.59 |
|
Alpha Capital Acquisition Company |
-0.57 |
|
Venus Acquisition Corporation |
-0.49 |
|
Alpha Capital Acquisition Company |
-0.49 |
|
Ventoux CCM Acquisition Corp. |
-0.41 |
|
Atlantic Coastal Acquisition Corp. II |
-0.36 |
|
L&F Acquisition Corp. |
-0.36 |
|
Nocturne Acquisition Corporation |
-0.35 |
|
Forafric Global PLC |
-0.32 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Social Capital Suvretta Holdings Corp. I |
0.64 |
|
Brookline Capital Acquisition Corp. |
0.57 |
|
FIRST TRUST ACTIVE FACTOR SMALL CAP ETF |
0.38 |
|
ALPS Clean Energy ETF |
0.37 |
|
Virtus AllianzGI Diversified Income & Convertible Fund |
0.37 |
|
Anfield U.S. Equity Sector Rotation ETF |
0.37 |
|
iShares MSCI ACWI ex US ETF |
0.36 |
|
Armada Hoffler Properties, Inc. |
0.36 |
|
AI Powered Equity ETF |
0.36 |
|
First Trust Active Factor Large Cap ETF |
0.36 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company’s lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.